APA-viite

Hassanein, M., Sahay, R. K., Malek, R., Shaltout, I., Djaballah, K., Demil, N., . . . Sifri, S. A. (2021). Real-World Safety and Effectiveness of iGlarLixi in People With Type 2 Diabetes who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study. J Endocr Soc.

Chicago-tyylinen lähdeviittaus

Hassanein, Mohamed, et al. "Real-World Safety and Effectiveness of IGlarLixi in People With Type 2 Diabetes Who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study." J Endocr Soc 2021.

MLA-viite

Hassanein, Mohamed, et al. "Real-World Safety and Effectiveness of IGlarLixi in People With Type 2 Diabetes Who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study." J Endocr Soc 2021.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.